Dr Demetris M Demetriou, MD | |
29645 W 14 Mile Rd, Ste 200, Farmington Hills, MI 48334-1666 | |
(248) 932-3700 | |
(248) 932-0958 |
Full Name | Dr Demetris M Demetriou |
---|---|
Gender | Male |
Speciality | Cardiovascular Disease (cardiology) |
Experience | 33 Years |
Location | 29645 W 14 Mile Rd, Farmington Hills, Michigan |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1790776946 | NPI | - | NPPES |
4270452 | Medicaid | MI |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RC0000X | Internal Medicine - Cardiovascular Disease | 4301058034 (Michigan) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Beaumont Hospital Royal Oak | Royal oak, MI | Hospital |
Beaumont Hospital - Grosse Pointe | Grosse pointe, MI | Hospital |
Beaumont Hospital - Farmington Hills | Farmington hills, MI | Hospital |
Beaumont Hospital - Dearborn | Dearborn, MI | Hospital |
Beaumont Hospital, Troy | Troy, MI | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Beaumont Medical Group- Specialty Services | 7214299866 | 787 |
News Archive
Metabolic urine profiling could provide an approach to understand what people have been eating, without them needing to tell you. Here, researchers from Imperial College London, Prof Gary Frost, Prof Elaine Holmes, and Dr. Isabel Garcia-Perez, explain why this could be invaluable to both nutritional research and individuals.
A higher surge of testosterone in competition, the so-called "winner effect," is not actually related to winning, suggests a new study of intercollegiate cross country runners.
Sigma® Life Science, the innovative biological products and services brand of Sigma-Aldrich®, today announced an extension to its award-winning CompoZr® product offering with the global release of the CompoZr Targeted Integration Kit, AAVS1. This kit provides a powerful method for the controlled transgene integration and expression of any gene in any human cell line using Sigma-Aldrich's proprietary CompoZr Zinc Finger Nuclease (ZFN) technology.
Good news for public health: Bioengineering researchers from the EPFL in Lausanne, Switzerland, have developed and patented a nanoparticle that can deliver vaccines more effectively, with fewer side effects, and at a fraction of the cost of current vaccine technologies.
Preoperative treatment with aromatase inhibitors increases the likelihood that postmenopausal women with estrogen receptor-positive breast cancer will be able to have breast-conserving surgery rather than a mastectomy, according to the results of a national clinical trial presented today at the Society of Surgical Oncology annual meeting in Orlando, Fla.
› Verified 7 days ago
Entity Name | Beaumont Medical Group- Specialty Services |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1578072906 PECOS PAC ID: 7214299866 Enrollment ID: O20180320002549 |
News Archive
Metabolic urine profiling could provide an approach to understand what people have been eating, without them needing to tell you. Here, researchers from Imperial College London, Prof Gary Frost, Prof Elaine Holmes, and Dr. Isabel Garcia-Perez, explain why this could be invaluable to both nutritional research and individuals.
A higher surge of testosterone in competition, the so-called "winner effect," is not actually related to winning, suggests a new study of intercollegiate cross country runners.
Sigma® Life Science, the innovative biological products and services brand of Sigma-Aldrich®, today announced an extension to its award-winning CompoZr® product offering with the global release of the CompoZr Targeted Integration Kit, AAVS1. This kit provides a powerful method for the controlled transgene integration and expression of any gene in any human cell line using Sigma-Aldrich's proprietary CompoZr Zinc Finger Nuclease (ZFN) technology.
Good news for public health: Bioengineering researchers from the EPFL in Lausanne, Switzerland, have developed and patented a nanoparticle that can deliver vaccines more effectively, with fewer side effects, and at a fraction of the cost of current vaccine technologies.
Preoperative treatment with aromatase inhibitors increases the likelihood that postmenopausal women with estrogen receptor-positive breast cancer will be able to have breast-conserving surgery rather than a mastectomy, according to the results of a national clinical trial presented today at the Society of Surgical Oncology annual meeting in Orlando, Fla.
› Verified 7 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Demetris M Demetriou, MD 29645 W 14 Mile Rd, Ste 200, Farmington Hills, MI 48334-1666 Ph: (248) 932-3700 | Dr Demetris M Demetriou, MD 29645 W 14 Mile Rd, Ste 200, Farmington Hills, MI 48334-1666 Ph: (248) 932-3700 |
News Archive
Metabolic urine profiling could provide an approach to understand what people have been eating, without them needing to tell you. Here, researchers from Imperial College London, Prof Gary Frost, Prof Elaine Holmes, and Dr. Isabel Garcia-Perez, explain why this could be invaluable to both nutritional research and individuals.
A higher surge of testosterone in competition, the so-called "winner effect," is not actually related to winning, suggests a new study of intercollegiate cross country runners.
Sigma® Life Science, the innovative biological products and services brand of Sigma-Aldrich®, today announced an extension to its award-winning CompoZr® product offering with the global release of the CompoZr Targeted Integration Kit, AAVS1. This kit provides a powerful method for the controlled transgene integration and expression of any gene in any human cell line using Sigma-Aldrich's proprietary CompoZr Zinc Finger Nuclease (ZFN) technology.
Good news for public health: Bioengineering researchers from the EPFL in Lausanne, Switzerland, have developed and patented a nanoparticle that can deliver vaccines more effectively, with fewer side effects, and at a fraction of the cost of current vaccine technologies.
Preoperative treatment with aromatase inhibitors increases the likelihood that postmenopausal women with estrogen receptor-positive breast cancer will be able to have breast-conserving surgery rather than a mastectomy, according to the results of a national clinical trial presented today at the Society of Surgical Oncology annual meeting in Orlando, Fla.
› Verified 7 days ago
Kali Allis, Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 28050 Grand River Ave, Farmington Hills, MI 48336 Phone: 248-417-8000 | |
Dr. Jyothsna Yalavarthi, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 28050 Grand River Ave, Farmington Hills, MI 48336 Phone: 734-464-0887 Fax: 734-402-0254 | |
Dr. Roberto Mauro Gamarra, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 30055 Northwestern Hwy, Suite 250, Farmington Hills, MI 48334 Phone: 248-985-5000 Fax: 248-985-5500 | |
Dr. Jared Grodman, DO Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 28050 Grand River Ave, Farmington Hills, MI 48336 Phone: 248-471-8232 | |
Justin Cykiert, Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 28050 Grand River Ave, Farmington Hills, MI 48336 Phone: 248-615-0777 | |
Larry A Wickless, M.D. Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 28080 Grand River Ave, Suite 306, Farmington Hills, MI 48336 Phone: 248-471-8982 Fax: 248-426-7350 | |
Dr. Allan W Chernick, MD Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 29645 W 14 Mile Rd, Ste 200, Farmington Hills, MI 48334 Phone: 248-932-3700 Fax: 248-932-0958 |